This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Prediction by Unipolar/Bipolar Illness, Average-Evoked Response, Catechol-O-Methyl Transferase, and Family History

Miron Baron, MD; Elliot S. Gershon, MD; Victor Rudy, MD; Wulff Z. Jonas; Monte Buchsbaum, MD

Arch Gen Psychiatry. 1975;32(9):1107-1111.

Abstract
• The antidepressant efficacy of lithium carbonate was assessed in a double-blind trial in 23 hospitalized depressed patients. Unequivocal response was significantly more frequent in bipolar than in unipolar depressed patients. Lithium carbonate responders had a greater visual average-evoked response amplitude increase in response to increased stimulus intensity, termed "augmenting."

No correlation could be demonstrated between lithium carbonate efficacy and either erythrocyte catechol-O-methyl tramsferase activity, age of symptom onset, number of hospitalizations, or family history of affective disorders.

Author Affiliations
From the Department of Research, Jerusalem Mental Health Center, Israel (Drs. Baron, Gershon, Rudy, and Mr. Jonas); and the Division of Clinical and Behavioral Research, National Institute of Mental Health, Bethesda, Md (Dr. Buchsbaum). Dr. Baron is now with Albert Einstein College of Medicine, New York. Dr. Gershon is now with the National Institute of Mental Health.

Footnotes
Accepted for publication Dec 11, 1974.

Reprint requests to the National Institute of Mental Health, Bldg 10, Rm 3N 218, Bethesda, MD 20014 (Dr. Gershon).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Advancing the pharmacological treatment of bipolar depression
Frangou
Adv. Psychiatr. Treat. 2005;11:28-37.
ABSTRACT | FULL TEXT  

What Is a "Mood Stabilizer"? An Evidence-Based Response
Bauer and Mitchner
Am. J. Psychiatry 2004;161:3-18.
ABSTRACT | FULL TEXT  

Relapse Prevention and Bipolar Disorder: A Focus on Bipolar Depression
Rapaport and Hales
Focus 2003;1:15-31.
ABSTRACT | FULL TEXT  

Current Therapeutic Profile of Lithium
Gershon and Soares
Arch Gen Psychiatry 1997;54:16-20.
ABSTRACT  

The Addition of Lithium to Carbamazepine: Antidepressant Efficacy in Treatment-Resistant Depression
Kramlinger and Post
Arch Gen Psychiatry 1989;46:794-800.
ABSTRACT  

Predictors of Drug Response in Depression
Joyce and Paykel
Arch Gen Psychiatry 1989;46:89-99.
ABSTRACT  

Pharmacologic Evidence for Specificity of Pursuit Dysfunction to Schizophrenia: Lithium Carbonate Associated With Abnormal Pursuit
Levy et al.
Arch Gen Psychiatry 1985;42:335-341.
ABSTRACT  

Lithium Carbonate Augmentation of Antidepressant Treatment: An Effective Prescription for Treatment-Refractory Depression
Heninger et al.
Arch Gen Psychiatry 1983;40:1335-1342.
ABSTRACT  

Lithium as an Antidepressant
Mendels et al.
Arch Gen Psychiatry 1979;36:845-846.
ABSTRACT  

Prediction of Treatment Outcome With Lithium
Carroll
Arch Gen Psychiatry 1979;36:870-878.
ABSTRACT  

The Erythrocyte Lithium-Plasma Lithium Ratio in Patients With Primary Affective Disorder
Ramsey et al.
Arch Gen Psychiatry 1979;36:457-461.
ABSTRACT  

Prediction of Tricyclic Antidepressant Response: A Critical Review
Bielski and Friedel
Arch Gen Psychiatry 1976;33:1479-1489.
ABSTRACT